What PSA Nadir Level Should Be Achieved After Irradiation For Prostate Cancer?

The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 21 de mayo del 1996

Share article

Arnold Herskovic, M.D., medical director, Radiation Oncology Department, Oakwood Hospital and Medical Center (Dearborn, MI), presented the results o a study which compared the overall survival of esophageal cancer patients treated with radiotherapy (RT) alone versus treatment with chemo-radiotherapy (CT-RT). The study was conducted by the Radiation Therapy Oncology Group (RTOG).

Traditional treatment with surgery and/or radiotherapy has provided poor results for patients with localized cancer of the esophagus. Earlier studies with combine CT-RT given before surgery, or as total treatment, suggested improved median and two-year survival.

In the study, 61 patients were randomized to receive CT-RT, and 62 to receive RT only. The CT-RT arm consisted of the anticancer drug 5-FU for four days, combined with cisplatin on day one of the chemotherapy cycle. the cycle was repeated four times, two during the radiation and two following. External beam radiation was delivered to the esophagus for five weeks, along with chemotherapy. patients receiving the RT-only arm received a higher dose of radiation.

The median survival was nine months for patients receiving radiation alone, compared to 14 months for patients receiving the combined modalities. There have been 62 deaths in the RT group (100%) versus 45 deaths in the combined CT-RT group (71%). In addition to improved survival, the combined CT-RT group showed superior tumor control and had acceptable side effects.

"The study results indicate that chemo-radiotherapy should become the new standard treatment for patients with esophageal cancer, which has traditionally been a disease with a poor prognosis," Derek Raghavan, M.D., professor and chief, Solid Tumor Oncology, Roswell Cancer Institute (Buffalo, NY), said at a press briefing today.

Findings at meeting cover biomarkers for detecting cancer, measuring PSA after prostatectomy

Oct 1, 2010 - A set of biomarkers may accurately detect prostate cancer, and a method for measuring low levels of prostate-specific antigen in men following radical prostatectomy could help guide treatment, according to two studies presented at the American Association for Cancer Research International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held from Sept. 27 to 30 in Denver.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información